Will mutant strains hurt prospects for Roche's flu-fighting newcomer Xofluza?

11th February 2019 Uncategorised 0

Xofluza, Roche’s bid to replace sales from the now-generic Tamiflu, has yet to catch on in the U.S., and new reports of viral resistance in Japan won’t help the drug’s case.

More: Will mutant strains hurt prospects for Roche's flu-fighting newcomer Xofluza?
Source: fierce